Pembrolizumab-Induced Steroid-Responsive Myoclonus

被引：2
作者：
Gallagher, Amy [1 ]
Murphy, Michael [1 ]
McDermott, Ray [2 ]
Alexander, Michael [3 ]
O'Dowd, Sean [1 ,4 ]
机构：
[1] Tallaght Univ Hosp, Dept Neurol, Dublin, Ireland
[2] Tallaght Univ Hosp, Dept Med Oncology, Dublin, Ireland
[3] Tallaght Univ Hosp, Dept Neurophysiol, Dublin, Ireland
[4] Trinity Coll Dublin, Acad Unit Neurol, Dublin, Ireland
来源：
MOVEMENT DISORDERS CLINICAL PRACTICE | 2022年 / 9卷 / 04期
关键词：
Pembrolizumab; myoclonus; immune checkpoint inhibitor; neurological; adverse;
D O I：
10.1002/mdc3.13453
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：546 / 550
页数：5
相关论文
共 8 条
[1]   Nivolumab-Induced Severe Akathisia in an Advanced Lung Cancer Patient [J].
Abe, Jiro ;
Sato, Taku ;
Tanaka, Ryota ;
Okazaki, Toshimasa ;
Takahashi, Satomi .
AMERICAN JOURNAL OF CASE REPORTS, 2016, 17 :880-882
[2]   Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial [J].
Cho, Jinhyun ;
Kim, Hae Su ;
Ku, Bo Mi ;
Choi, Yoon-La ;
Cristescu, Razvan ;
Han, Joungho ;
Sun, Jong-Mu ;
Lee, Se-Hoon ;
Ahn, Jin Seok ;
Park, Keunchil ;
Ahn, Myung-Ju .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (24) :2162-+
[3]   Neurological immune-related adverse events associated with immune checkpoint inhibitors: A review of the literature [J].
Fan, Siyuan ;
Ren, Haitao ;
Zhao, Luo ;
Yin, Jian ;
Feng, Guodong ;
Wang, Jiawei ;
Guan, Hongzhi .
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 (06) :291-298
[4]   Neurological Complications Associated With Anti-Programmed Death 1 (PD-1) Antibodies [J].
Kao, Justin C. ;
Liao, Bing ;
Markovic, Svetomir N. ;
Klein, Christopher J. ;
Naddaf, Elie ;
Staff, Nathan P. ;
Liewluck, Teerin ;
Hammack, Julie E. ;
Sandroni, Paola ;
Finnes, Heidi ;
Mauermann, Michelle L. .
JAMA NEUROLOGY, 2017, 74 (10) :1216-1222
[5]   Neurological Immune Related Adverse Events Associated with Nivolumab, Ipilimumab, and Pembrolizumab Therapy-Review of the Literature and Future Outlook [J].
Moehn, Nora ;
Beutel, Gernot ;
Gutzmer, Ralf ;
Ivanyi, Philipp ;
Satzger, Imke ;
Skripuletz, Thomas .
JOURNAL OF CLINICAL MEDICINE, 2019, 8 (11)
[6]   Neurotoxicity from immune-checkpoint inhibition in the treatment of melanoma: a single centre experience and review of the literature [J].
Spain, L. ;
Walls, G. ;
Julve, M. ;
O'Meara, K. ;
Schmid, T. ;
Kalaitzaki, E. ;
Turajlic, S. ;
Gore, M. ;
Rees, J. ;
Larkin, J. .
ANNALS OF ONCOLOGY, 2017, 28 (02) :377-385
[7]   Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials A Systematic Review and Meta-analysis [J].
Wang, Yucai ;
Zhou, Shouhao ;
Yang, Fang ;
Qi, Xinyue ;
Wang, Xin ;
Guan, Xiaoxiang ;
Shen, Chan ;
Duma, Narjust ;
Aguilera, Jesus Vera ;
Chintakuntlawar, Ashish ;
Price, Katharine A. ;
Molina, Julian R. ;
Pagliaro, Lance C. ;
Halfdanarson, Thorvardur R. ;
Grothey, Axel ;
Markovic, Svetomir N. ;
Nowakowski, Grzegorz S. ;
Ansel, Stephen M. ;
Wang, Michael L. .
JAMA ONCOLOGY, 2019, 5 (07) :1008-1019
[8]   Phosphodiesterase 10A IgG A novel biomarker of paraneoplastic neurologic autoimmunity [J].
Zekeridou, Anastasia ;
Kryzer, Thomas ;
Guo, Yong ;
Hassan, Anhar ;
Lennon, Vanda ;
Lucchinetti, Claudia F. ;
Pittock, Sean ;
McKeon, Andrew .
NEUROLOGY, 2019, 93 (08) :E815-E822
1